Market Overview

UPDATE: Topeka Capital Markets Upgrades Monsanto to Buy on Improved Risk Profile

Share:
Related MON
Q3 13F Roundup: How Buffett, Einhorn, Paulson, And Others Adjusted Their Portfolio
6 Stocks To Watch For October 4, 2017
Minnesota puts restrictions on dicamba herbicide (Seeking Alpha)

Topeka Capital Markets raised its rating on Monsanto (NYSE: MON) from Hold to Buy with a $107 price target.

Topeka Capital Markets said, "When initiating coverage with a Hold rating in Sept., we acknowledged MON's positive commercial momentum, and anticipated positive Ag fundamentals – particularly in corn –would remain a favorable tailwind for the Company. These aspects of the MON story remain intact. Our cautiousness was based primarily on perceptions regarding questions about the diminishing effectiveness of certain biotech traits, which could ultimately undermine MON's valuation, along with perceived uncertainty regarding the impending expiration of MON's RR patent in 2014. We now believe these potential issues could be less acute, if not benign, at least in the relatively near-term."

Monsanto closed at $88.42 on Monday.

Latest Ratings for MON

DateFirmActionFromTo
Oct 2017Wells FargoMaintainsMarket Perform
Oct 2017BarclaysMaintainsEqual-Weight
Aug 2017UBSDowngradesBuyNeutral

View More Analyst Ratings for MON
View the Latest Analyst Ratings

Posted-In: Topeka Capital MarketsAnalyst Color Upgrades Intraday Update Analyst Ratings

 

Related Articles (MON)

View Comments and Join the Discussion!

Partner Center